Press Releases

Il Consorzio VERDI, coordinato dal Dipartimento di Salute della Donna e del Bambino (SDB) dell’Università di Padova e dalla Fondazione Penta ETS,

The VERDI Consortium, coordinated by the University of Padua and Fondazione Penta ETS (Italy), has received an additional €5 million funding from the European Union (EU). Thanks to this contribution,

Padua (Italy), 7 December 2022 – Leading public health experts from around the globe are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly…

Padova, 30 giugno 2022 Il vaccino Pfizer-BioNTech BNT162b2 (Comirnaty) offre una protezione moderata dalla variante Omicron nei bambini dai 5 agli 11 anni. Lo dimostra un ampio studio appena pubblicato…

Padua, 30 June 2022 – A large study on the effectiveness of the Pfizer Covid-19 vaccine in children aged 5-11 was published in 

Geneva, 26 April 2022 – A large study focusing on newborn babies with clinically diagnosed sepsis has revealed the impact of antibiotic resistance on neonatal sepsis, a major cause of…

Ginevra, 26 Aprile 2022 – Un importante studio sui neonati ha rivelato l’impatto della resistenza agli antibiotici sulla sepsi neonatale, una delle principali cause di morte tra i neonati.

Funded by the Horizon Europe programme, RBDCOV will test the efficacy, tolerability, and safety of the vaccine against the different variants of COVID-19 using a recombinant protein.

UCL press release A once-a-day antiretroviral medicine that is low-cost and easy for children to take is also more effective at suppressing HIV than standard treatments,

The results of the study show that there is no clear advantage for adopting a shorter 5-day course, with a loading dose, over the standard 10-day course in infants under…

Today we launch VERDI, a project that prioritizes women and children in the research on new coronavirus variants The University of Padua and Penta Foundation are leaders of VERDI,

A study published in the Pediatrics journal shows that children with mild forms of COVID-19 develop a greater and longer lasting antibody response than that of adults.

Università degli Studi di Padova, Istituto Zooprofilattico Sperimentale delle Venezie e Penta presentano nuovi dati sulla durata della protezione immunitaria contro SARS-CoV-2 nei bambini Uno studio pubblicato in questi giorni…

Parte da Padova il progetto europeo NeoIPC, che mira a ridurre le infezioni e la trasmissione di batteri resistenti nelle unità di terapia intensiva neonatale. Padova,

NeoIPC, a project seeking to reduce the transmission of resistant bacteria in neonatal intensive care units, has just launched.

Un progetto a guida italiana sostenuto da UniCredit Foundation Padova, 21 Aprile 2021 – Parte il progetto CORONA: bambini e COVID-19, sostenuto da UniCredit Foundation e condotto dalla Fondazione Penta di…

An Italian-led project supported by the UniCredit Foundation to study the impact of the coronavirus on children.

Today marks the official launch of UNIVERSAL, the newly funded European-African clinical research partnership that aims to develop two antiretroviral formulations for children living with HIV and to speed up…